Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-17
1993-10-05
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514316, 514318, 514320, 514331, 546187, 546190, 546193, 546207, 546208, 546209, 546231, 546233, 546234, 546235, 546238, 546316, 546318, 546320, 546331, A61K 31445, C07D40112, C07D21132
Patent
active
052505421
ABSTRACT:
3,4,4-trisubstitutedpiperidinyl-N-alkylcarboxylates and intermediates for their preparation are provided. These piperidine-N-alkylcarboxylates are useful as peripheral opioid antagonists.
REFERENCES:
patent: 3498978 (1970-02-01), Clark et al.
patent: 3884916 (1975-05-01), Janssen et al.
patent: 3936468 (1976-01-01), Yamamoto et al.
patent: 3954779 (1976-03-01), Smith et al.
patent: 3991199 (1976-09-01), Berger
patent: 4081450 (1978-04-01), Zimmerman
patent: 4115400 (1978-11-01), Zimmerman
patent: 4141980 (1979-04-01), Berger
patent: 4175197 (1979-07-01), Zimmerman
patent: 4191771 (1980-11-01), Zimmerman
patent: 4284635 (1981-03-01), Zimmerman
patent: 4581456 (1986-06-01), Barnett
patent: 4663460 (1987-07-01), Barnett
patent: 4788283 (1988-02-01), Karrer
patent: 4891379 (1990-03-01), Zimmerman et al.
patent: 4992450 (1991-07-01), Zimmerman et al.
patent: 5086054 (1992-02-01), Parish
patent: 5159081 (1992-10-01), Cantrell et al.
"New Structural Concepts for Narcotic Antagonist Defined in a 4-Phenylpiperidine Series", of Zimmerman, et al., Nature, 275, No. 5678, pp. 332-334 (1978).
"Selective Opioid Receptor Agonist and Antagonist; Research Tools and Potential Therapeutic Agents", J. Med. Chem., 1990, 33, 895-902 of Zimmerman, et al.
Leander, et al., in the paper "Novel Phenylpiperidine Opioid Antagonist and Partial Antagonists; Effects on Fluid Consumption", European Journal of Pharmacology, 81, 185-192 (1982).
Oh-ishi, et al., Journal of Medicinal Chemistry, 1973, vol. 16, 12, 1376-1378.
Leander, et al., in the paper entitled "Antagonism of Bremazocine-Induced Urination as a Test for Kappa-Opioid Receptor Antagoinists Within the Phenylpiperidine Series", Drug Development Research 4, 421-427 (1984).
Baile, et al., in a paper entitled "Opiate Antagonists and Agonists and feeding in Sheep", Philsiology and Behavior, 26, 1019-23 (1981).
Leander in a paper entitled "A Kappa Opioid Affect; Increased Urination in the Rat", The Journal of Pharmacology and Therapeutics 224, No. 1, 89-94 (1983).
B. Huegi, et al., Eur. J. Med. Chem.-Chim. Ther. 1934-19, No. 6, pp. 487-494.
Cantrell Buddy E.
Zimmerman Dennis M.
Covington Raymond
Eli Lilly and Company
Ivy C. Warren
Vorndran-Jones MaCharri R.
Whitaker Leroy
LandOfFree
Peripherally selective piperidine carboxylate opioid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peripherally selective piperidine carboxylate opioid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peripherally selective piperidine carboxylate opioid antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1004078